Predictive Oncology Completes $344 Million Private Placement to Launch Aethir (ATH) Treasury Strategy

Foresight News reports that Predictive Oncology Inc. announced today that the company has conducted two private placement transactions, aiming to raise approximately $344 million to support its digital asset treasury strategy, primarily holding the native utility token of the Aethir (ATH) ecosystem. The transaction overview indicates that the company will raise approximately $344.4 million through private investment in public equity (PIPEs), including the issuance of approximately 66.7 million shares of common stock (or prepaid warrants to purchase common stock) at a price of $0.7751 per share, expected to generate approximately $51.7 million in cash proceeds ("Cash PIPE"), as well as prepaid warrants to purchase up to 223.6 million shares of common stock at an exercise price equal to the issuance price of each warrant minus $0.01, expected to exchange for approximately $292.7 million in nominal value, of which $173.3 million represents discounted value involving locked and unlocked Aethir tokens. The prepaid warrants issued in the Crypto PIPE will become exercisable immediately upon shareholder approval. The PIPE transactions are expected to close simultaneously around October 2, 2025, subject to customary closing conditions. The company plans to use ATH's physical contributions to support its digital asset treasury strategy and intends to use the remaining net proceeds from the PIPE transactions primarily to acquire ATH on the open market to further support this strategy, as well as for working capital and general corporate purposes.